Vascular-specific growth factors and blood vessel formation - PubMed (original) (raw)

Review

. 2000 Sep 14;407(6801):242-8.

doi: 10.1038/35025215.

Affiliations

• PMID: 11001067
• DOI: 10.1038/35025215

Review

Vascular-specific growth factors and blood vessel formation

G D Yancopoulos et al. Nature. 2000.

Abstract

A recent explosion in newly discovered vascular growth factors has coincided with exploitation of powerful new genetic approaches for studying vascular development. An emerging rule is that all of these factors must be used in perfect harmony to form functional vessels. These new findings also demand re-evaluation of therapeutic efforts aimed at regulating blood vessel growth in ischaemia, cancer and other pathological settings.

PubMed Disclaimer

Similar articles

• [Genetic plan for the formation of cardiovascular system].
  Umetani M, Kodama T, Hamakubo T. Umetani M, et al. Tanpakushitsu Kakusan Koso. 2000 Sep;45(13 Suppl):2235-42. Tanpakushitsu Kakusan Koso. 2000. PMID: 11021229 Review. Japanese. No abstract available.
• Role of vascular endothelial growth factor and vascular endothelial growth factor receptors in vascular development.
  Carmeliet P, Collen D. Carmeliet P, et al. Curr Top Microbiol Immunol. 1999;237:133-58. doi: 10.1007/978-3-642-59953-8_7. Curr Top Microbiol Immunol. 1999. PMID: 9893349 Review. No abstract available.
• VEGFs, receptors and angiogenesis.
  Veikkola T, Alitalo K. Veikkola T, et al. Semin Cancer Biol. 1999 Jun;9(3):211-20. doi: 10.1006/scbi.1998.0091. Semin Cancer Biol. 1999. PMID: 10343072 Review.
• [Angiogenesis--vascular endothelial growth factor and its receptors].
  Shibuya M. Shibuya M. Hum Cell. 1999 Mar;12(1):17-24. Hum Cell. 1999. PMID: 10457901 Review. Japanese.
• Regulation of angiogenesis via vascular endothelial growth factor receptors.
  Veikkola T, Karkkainen M, Claesson-Welsh L, Alitalo K. Veikkola T, et al. Cancer Res. 2000 Jan 15;60(2):203-12. Cancer Res. 2000. PMID: 10667560 Review. No abstract available.

Cited by

• Reassessment of arterial versus venous perfusion of diabetic retinal neovascularization using ultrawide-field fluorescein angiography.
  Lin BR, Carletti P, Yi J, Rosenfeld PJ, Russell JF. Lin BR, et al. Graefes Arch Clin Exp Ophthalmol. 2024 Oct 8. doi: 10.1007/s00417-024-06650-3. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 39377805
• Critical appraisal of the chorioallantoic membrane model for studying angiogenesis in preclinical research.
  Shekatkar M, Kheur S, Deshpande S, Sakhare S, Sanap A, Kheur M, Bhonde R. Shekatkar M, et al. Mol Biol Rep. 2024 Sep 28;51(1):1026. doi: 10.1007/s11033-024-09956-x. Mol Biol Rep. 2024. PMID: 39340708 Review.
• Combination of JAKi and HDACi Exerts Antiangiogenic Potential in Cutaneous T-Cell Lymphoma.
  Karagianni F, Piperi C, Valero-Diaz S, Amato C, Vaque JP, Casar B, Papadavid E. Karagianni F, et al. Cancers (Basel). 2024 Sep 17;16(18):3176. doi: 10.3390/cancers16183176. Cancers (Basel). 2024. PMID: 39335148 Free PMC article.
• JAK inhibitors inhibit angiogenesis by reducing VEGF production from rheumatoid arthritis-derived fibroblast-like synoviocytes.
  Anjiki K, Hayashi S, Ikuta K, Suda Y, Kamenaga T, Tsubosaka M, Kuroda Y, Nkano N, Maeda T, Tsumiyama K, Matsumoto T, Kuroda R, Matsubara T. Anjiki K, et al. Clin Rheumatol. 2024 Sep 20. doi: 10.1007/s10067-024-07142-9. Online ahead of print. Clin Rheumatol. 2024. PMID: 39302595
• Opportunities and Challenges of Small Molecule Inhibitors in Glioblastoma Treatment: Lessons Learned from Clinical Trials.
  Hoosemans L, Vooijs M, Hoeben A. Hoosemans L, et al. Cancers (Basel). 2024 Aug 29;16(17):3021. doi: 10.3390/cancers16173021. Cancers (Basel). 2024. PMID: 39272879 Free PMC article. Review.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Nature Publishing Group
  • Ovid Technologies, Inc.

• Other Literature Sources

  • The Lens - Patent Citations